Request Deal Involvement
Gilead Sciences to acquire a 49.9% stake in Pionyr for $275m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Bank of America
legal advisors
Ropes & Gray
pr advisors
Canale Communications
financial advisors
Centerview Partners
legal advisors
Latham & Watkins
or
Principals
bidder
GILEAD SCIENCES
target
PIONYR IMMUNOTHERAPEUTICS INC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite